Imaging Biomarkers in Immunotherapy


Immune-based therapies have been in use for decades but recent work with immune checkpoint inhibitors has now changed the landscape of cancer treatment as a whole. While these advances are encouraging, clinicians still do not have a consistent biomarker they can rely on that can accurately select patients or monitor response. Molecular imaging technology provides a noninvasive mechanism to evaluate tumors and may be an ideal candidate for these purposes. This review provides an overview of the mechanism of action of varied immunotherapies and the current strategies for monitoring patients with imaging. We then describe some of the key researches in the preclinical and clinical literature on the current uses of molecular imaging of the immune system and cancer.

DOI: 10.4137/BIC.S31805

Extracted Key Phrases

4 Figures and Tables

Citations per Year

Citation Velocity: 18

Averaging 18 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Juergens2016ImagingBI, title={Imaging Biomarkers in Immunotherapy}, author={Rosalyn A. Juergens and Katherine A. Zukotynski and Amit Singnurkar and Denis P. Snider and John F Valliant and Karen Yvonne Gulenchyn}, booktitle={Biomarkers in cancer}, year={2016} }